Analyst Ratings for Amneal Pharmaceuticals (AMRX)
AMRX Rating Summary
AMRX Price Target Summary
- Highest: $25.00 (UBS)
- Lowest: $13.00 (Piper Sandler)
- Average: $17.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$17.80 (+0.7%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$17.80 (+0.7%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/24/2026 | DA Davidson | Garik Shmois | New Coverage | Neutral (N/A) |
N/A (N/A) |
17.91 (17.68) |
-1.28% | Details |
| 4/17/2026 | UBS » Updated 8/3/2026 |
Ashwani Verma | New Coverage | Buy (N/A) |
25.00 (23.00) |
13.05 (17.68) |
35.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
